STOCK TITAN

Kyndryl Holdings, Inc. (KD) director awarded 17,844 RSUs

(Moderate)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Kyndryl Holdings, Inc. director Howard I Ungerleider reported an acquisition of 17,844 shares of common stock on July 30, 2026, through a grant of restricted stock units priced at $13.45 per share. These RSUs vest in full on the earlier of the grant’s first anniversary and the company’s 2027 Annual Meeting of Stockholders, subject to the stated meeting-timing condition. Following this award, Ungerleider directly holds 97,930 shares of Kyndryl common stock.

Positive

  • None.

Negative

  • None.
Insider Ungerleider Howard I
Role Director
Type Security Shares Price Value
Grant/Award Common Stock F1 17,844 $13.45 $240K
Holdings After Transaction: Common Stock — 97,930 shares (Direct)
Footnotes (1)
  1. F1. Represents a grant of restricted stock units which will vest in full on the earlier of the anniversary of the grant date and the date of the Issuer's 2027 Annual Meeting of Stockholders (provided that the date of such annual meeting is at least 50 weeks after the date of the Issuer's 2026 Annual Meeting of Stockholders).
Restricted stock units granted 17,844.0000 shares Equity award to director on 2026-07-30
Grant price per share $13.4500 Reported transaction price per share for RSU grant
Total shares following transaction 97,930.0000 shares Director’s Kyndryl common stock holdings after the award
Transaction date 2026-07-30 Date of the reported RSU grant
restricted stock units financial
"Represents a grant of restricted stock units which will vest in full on the earlier"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
vest in full financial
"restricted stock units which will vest in full on the earlier of the anniversary"
Annual Meeting of Stockholders regulatory
"the date of the Issuer's 2027 Annual Meeting of Stockholders"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What transaction involving Kyndryl (KD) did Howard I Ungerleider report?

Howard I Ungerleider reported a grant of 17,844 Kyndryl restricted stock units on July 30, 2026, at $13.45 per share. The award is reported as an acquisition of common stock equivalents and increased his direct holdings to 97,930 shares.

How many Kyndryl (KD) shares were granted to Howard I Ungerleider and at what price?

He received 17,844 restricted stock units tied to Kyndryl common stock at a reported grant price of $13.45 per share. This reflects a compensation-related equity award rather than an open-market purchase of shares.

When will the 17,844 restricted stock units from Kyndryl (KD) vest?

The 17,844 restricted stock units vest in full on the earlier of the first anniversary of the grant date and Kyndryl’s 2027 Annual Meeting of Stockholders. Vesting at that meeting is conditioned on it occurring at least 50 weeks after the 2026 annual meeting.

What is Howard I Ungerleider’s Kyndryl (KD) share ownership after this grant?

After the grant, Howard I Ungerleider directly holds 97,930 shares of Kyndryl common stock. This total reflects his position following the acquisition of 17,844 restricted stock units reported in the July 30, 2026 equity award.

Was Howard I Ungerleider’s Kyndryl (KD) equity grant made under a Rule 10b5-1 plan?

The filing’s Rule 10b5-1 checkbox is not selected, and the footnote describes the award as a standard grant of restricted stock units. There is no indication in the disclosure that this compensation grant was executed under a Rule 10b5-1 trading plan.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Ungerleider Howard I

(Last)(First)(Middle)
ONE VANDERBILT AVENUE, 15TH FLOOR

(Street)
NEW YORK NEW YORK 10017

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Kyndryl Holdings, Inc. [ KD ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
07/30/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock07/30/2026A17,844(1)A$13.4597,930D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Represents a grant of restricted stock units which will vest in full on the earlier of the anniversary of the grant date and the date of the Issuer's 2027 Annual Meeting of Stockholders (provided that the date of such annual meeting is at least 50 weeks after the date of the Issuer's 2026 Annual Meeting of Stockholders).
Remarks:
Exhibit List - Exhibit 24.1 - Power of Attorney
/s/ Ann Schlaffman, attorney-in-fact08/03/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)